TF1
TF1 has been studied in 2 papers since 2025: none in people yet, 1 in animals, 1 in cells; 1 in the past year. The research so far is in animals and cells. The newest paper, Oct 27, 2026: “Theaflavin monomers extend Caenorhabditis elegans lifespan through insulin/IGF-1 signaling pathway”.
1 new paper in 30 daysSee all 2 papers on TF1
At a glance
The findings reach worms or flies, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Guangdong Provincial Department of Science and Technology
- Model organisms1
- Cells1
What did studies of TF1 find?
3Studies of TF1 measured 3 outcomes: ubiquitin-proteasome system-related gene expression, insulin/IGF-1 signaling and lifespan.
Ubiquitin-proteasome system-related gene expression
upin worms1
1 study
Ubiquitin-proteasome system-related gene expression
upin worms1
TF1 increases ubiquitin-proteasome system-related gene expression in worms.
“Furthermore, TF1 upregulated the ubiquitin-proteasome system-related gene levels.”
Model organisms
Theaflavin monomers extend Caenorhabditis elegans lifespan through insulin/IGF-1 signaling pathway
Journal of Functional Foods
Insulin/IGF-1 signaling
downin worms1
1 study
Insulin/IGF-1 signaling
downin worms1
TF1 inhibits insulin/IGF-1 signaling in worms.
“Mechanistically, TF1 and TF2B suppressed the DAF-2-mediated insulin/IGF-1 signaling pathway.”
Model organisms
Theaflavin monomers extend Caenorhabditis elegans lifespan through insulin/IGF-1 signaling pathway
Journal of Functional Foods
Lifespan
upin worms1
1 study
Lifespan
upin worms1
TF1 extends lifespan in worms.
“100 μM TF1 and 500 μM TF2B markedly increased lifespan”
Model organisms100 μM
Theaflavin monomers extend Caenorhabditis elegans lifespan through insulin/IGF-1 signaling pathway
Journal of Functional Foods